- Home
- BGI vs TURN Comparison
BGI vs TURN Comparison
Compare BGI & TURN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGI
- TURN
- Stock Information
- Founded
- BGI 1879
- TURN 1981
- Country
- BGI Canada
- TURN United States
- Employees
- BGI N/A
- TURN N/A
- Industry
- BGI
- TURN Finance/Investors Services
- Sector
- BGI
- TURN Finance
- Exchange
- BGI Nasdaq
- TURN Nasdaq
- Market Cap
- BGI 31.1M
- TURN 35.7M
- IPO Year
- BGI 2005
- TURN N/A
- Fundamental
- Price
- BGI $1.60
- TURN $3.59
- Analyst Decision
- BGI
- TURN
- Analyst Count
- BGI 0
- TURN 0
- Target Price
- BGI N/A
- TURN N/A
- AVG Volume (30 Days)
- BGI 15.5K
- TURN 37.8K
- Earning Date
- BGI 12-31-2024
- TURN 02-18-2025
- Dividend Yield
- BGI N/A
- TURN N/A
- EPS Growth
- BGI N/A
- TURN N/A
- EPS
- BGI N/A
- TURN N/A
- Revenue
- BGI $131,596,264.00
- TURN $129,297.00
- Revenue This Year
- BGI N/A
- TURN N/A
- Revenue Next Year
- BGI N/A
- TURN N/A
- P/E Ratio
- BGI N/A
- TURN N/A
- Revenue Growth
- BGI 4.01
- TURN 6.32
- 52 Week Low
- BGI $1.46
- TURN $3.12
- 52 Week High
- BGI $4.88
- TURN $4.47
- Technical
- Relative Strength Index (RSI)
- BGI 37.69
- TURN 50.97
- Support Level
- BGI $1.58
- TURN $3.61
- Resistance Level
- BGI $1.67
- TURN $3.80
- Average True Range (ATR)
- BGI 0.09
- TURN 0.12
- MACD
- BGI 0.02
- TURN -0.02
- Stochastic Oscillator
- BGI 33.31
- TURN 28.38
About BGI Birks Group Inc.
Birks Group Inc is a part of the leisure industry. The company designs, develops, produces, and retails fine jewelry, timepieces, and gifts. Its operating segments include Retail and Other. The company generates maximum revenue from the Retail segment. Its retail segment consists of retail operations whereby it operates stores in Canada under the Maison Birks, Brinkhaus, Graff, and Patek Phillippe brands. The other segment consists mainly of wholesale business, e-commerce business, and gold exchange business.
About TURN 180 Degree Capital Corp.
180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.